Biocompatibility / Safety

All appropriate biocompatibility tests have been performed. Biocompatibility of HYABELL® has been assessed according to the ISO10993: 2009 standards and encompassed all tests.

In addition to the international standard tests, further longer intracutaneous reactivity evaluation has been performed with HYABELL® Ultra (24 mg/ml). Results of 12-month implantation tests have demonstrated that HYABELL® has high tolerance and biocompatibility profile.

 

Efficacy

HYABELL® products with lidocaine are easy to apply, providing a comfortable and gentle injection experience according to patients' and doctors' assessments.

HYABELL® products contain 0.3% lidocaine. For doctors, it facilitates the efficacy of treatments in general.
For patients, it improves the comfort by reducing pain, enhancing patients' satisfaction during and after the treatment.

Contact

How to contact us

Adoderm GmbH

Elisabeth-Selbert-Str. 5, D-40764 Langenfeld, Germany

Tel: +49 (0) 2173 / 101 91 80

Fax: +49 (0) 2173 / 101 91 82

E-Mail: info@hyabell.com / info@adoderm.com

Internet: www.adoderm.com


Disclaimer:

All texts, graphics, photos and videos on this website have their copyright by Adoderm GmbH.
No third-party use in print or any digital way (example, social media as in Youtube, Facebook etc. ) is allowed. Any misuse is forbidden and will be legally prosecuted. All international laws apply.